Skip to content
healthcare.dev

NADOLOL

NDC 46708-403, NADOLOL, tablet, from Alembic Pharmaceuticals Limited.

Product NDC
46708-403
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211763
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-403 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NADOLOL40 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
46708-403-304670804033030 TABLET in 1 BOTTLE (46708-403-30)
46708-403-3146708040331100 TABLET in 1 BOTTLE (46708-403-31)
46708-403-91467080403911000 TABLET in 1 BOTTLE (46708-403-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0bd202e3-c673-4945-b828-1a5bc6a896ae

Use it

Look up 46708-403 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-403 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-403. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.